A report has claimed that, researchers have found a way to make HIV-resistant cells by tethering HIV-fighting antibodies to immune cells, in turn creating a cell population resistant to the virus.
These HIV-resistant cells can quickly replace diseased cells, making it more effective than other therapies – and potentially curing the deadly disease.
The researchers plan to collaborate with investigators at City of Hope’s Center for Gene Therapy, in California, to evaluate this new therapy in efficacy and safety tests, as required by federal regulations, prior to testing in patients.
The method involves “tethering HIV-fighting antibodies to immune cells, creating a cell population that is resistant to the virus,” according to a report in Science Daily.
Experiments in the lab showed that the HIV-resistant cells replaced diseased cells, with antibodies clinging on to their surface, shielding them from HIV.
The researchers also confirmed that this new method proved more effective than the conventional way of treating HIV patients through “free-floating antibodies”.
According to the report, plans are in pipeline for the researchers, led by senior author Dr Richard Lerner, to collaborate with other scientists at City of Hope’s Center for Gene Therapy to evaluate the findings and perform further tests in accordance with federal laws before it can be tested on patients.
According to WHO, there were approximately 36.7 million people living with HIV at the end of 2015.